Mergers and Acq...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
Pandion Therapeutics
Mergers and Acquisitions
4/1/21 at 15:50
Share at
News editor
press@blackterminal.com
Merck has completed its acquisition of Pandion Therapeutics for $60 per share.
Pandion Therapeutics
Review
Source:
merck.com
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
Globaltrak reported for the 3 months of 2024 by RAS
5/7/24
GTRK
RSC Energia reported for 2023 by IFRS
5/7/24
RKKE
Novabev Group reported for 3 months of 2024 by RAS
5/7/24
BELU
Ingrad reported for the 3 months of 2023 by RAS
5/7/24
INGR
Seligdar started installation of process equipment at Hvoynoye
5/7/24
SELG
Lenenergo may buy LOESK
5/7/24
LSNG
Lenenergo reported for 3 months of 2024 by RAS
5/6/24
LSNG
Levenguc reported for 2023 by IFRS
5/6/24
LVHK
Tatneft reported for 3 months of 2024 by RAS
5/6/24
TATN
M.Video launched the retailer's first multi-brand smartphone zones
5/6/24
MVID
«
Previous
5
6
7
8
9
10
11
12
13
14
»
Next
BlackTerminal.com 2016 - 2024.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)